Presenter's Information

William F. Fearon, MD

Country USA
Specialty Interventional Cardiologist
  1. Coronary Physiology for Left Main and Multivessel Disease
  2. Long-Term Final 5-Year Results of FAME-3 Trial
  3. Long-Term Follow-Up and Other Key Sub-Study of the FAME 3 Trial
  4. CT Based Coronary Physiology in Pactice - Update in 2025
  5. 3-Year Follow-Up of the FAME 3 Trial
  6. Update on the ALL-RISE Trial (Advancing Cath Lab Results With FFR-Angio Physiology Assessment)
  7. How I Use Angio-Based Physiology to Guide My Case in the Cath Lab: Practical Appraisal
  8. The Series of FAME Studies: A Paradigm Shift in Our Thinking About Interventional Cardiology
  9. Unmet Need for FFR in LM PCI
  10. True Message from FAME 3
  11. Role of PCI in Multivessel CAD: What Do the New Guidelines Say?
  12. FFR-Guided PCI for Multivessel CAD in 2022
  13. Angiography-derived Coronary Physiology
  14. Complete Revascularization for MVD and LM: Anatomic or Functional Concept
  15. Angio-guided vs. FFR-guided PCI
  16. FAME III: The Lessons from FAME Studies, What We Learned
  17. FAST FFR
  18. Many Pressure Wires in Cath Lab: Advantages and Disadvantages
  19. FAME 2: 3-year Clinical and Cost-effectiveness Outcomes of FFR-guided PCI in Patients with Coronary Artery Disease
  20. Non-Invasive FFR Assessment
  21. FFR Is Still Standard!
  22. Is Anatomic Complete Revascularization Really Necessary?
  23. PCI vs. CABG in LM and MVD: Time to Apply FFR for Decision-Making: Updated Data and FAME-3
  24. Post-PCI FFR: What Does It Mean and Should We Measure It?
  25. Are We Ready to Move from FFR to Resting Indices?
  26. The FUTURE Trial and Current Evidence of FFR Guided PCI: Is There Warning Sign?
  27. Routine Assessment of the Microcirculation and Absolute Flow: A Glimpse to the Future
  28. FFR Is Underutilized - Beyond Just Intermediate Lesions!
  29. Left Main
  30. Coronary Blood Flow, Pressure and Resistance: How to Integrate, Interpret and Apply in Practice
  31. Update on FAME 3 Trial
  32. Who Needs Adenosine or iFR, I Have cFFR (Contrast FFR): Update on the CONTRAST Study
  33. Invasive Evaluation of the Patient with Chest Pain and No Obstructive CAD
  34. Integrated Use of IMR and FFR in Daily Practice
  35. The Ultimate: FAME 3
  36. FFR State-of-the-Art: Clinical Applications and New Technologies
  37. MVD and FAME Studies
  38. Practical Set-up
  39. Update of the FAME 3 Trial
  40. Experimental Basis and Clinical Validation of FFR
  41. Assessment and Clinical Relevance of Coronary Microvasculature
  42. For Ischemia, Forget VP and Focus on the Ischemic Lesion!
  43. [FFR Use at CathLab: More & Better] Unmet Need: FAME 3
  44. FFR Clinical Trials: Review and Update
  45. FFR Evaluation: Optimal Measurement and Common Mistakes
  46. Clinical Benefit of FFR
  47. Tips and Trick
  48. How to Integrate FAME I, FAME II and COURAGE?
  49. Importance of the Coronary Microvasculature
  50. FFR in Acute Coronary Syndrome: Culprit and Non-culprit Lesion
  51. FAME2 & COURAGE Trials: Going Functional, It\'s Solution!
  52. Update 2013: FFR-guided Decision Making
  53. Roles of FFR in Unstable Angina and NSTEMI
  54. Clinical Application of IMR : Evidence and Practice
  55. Sidebranch Compromise: Mechanism and Implication
  56. How and Why to Assess the Coronary Microvasculature
  57. Gap Between Anatomy and Function
  58. FFR Clinical Trials and Applications: Make the PCI Practice Changed
  59. Beyond FAME: The Integration of Invasive Ischemia Assessment(FFR) into Clinical Practice
  60. When to Use IVUS and When Would FFR Be a Better Choice?
  61. FFR Guided PCI
  62. Integrated Decision Making in Bifurcation Lesion (IVUS vs. FFR)
  63. Practice Guideline for FFR Use (FAME Study)
  64. FFR in Multivessel Disease: Results of the F.A.M.E. Multicenter, International, Randomized Study Comparing FFR Guided PCI to Angio Guided PCI in Patients with Multivessel CAD
  65. Fundamentals, Techniques, Pitfalls, and Limitations of FFR Interpretation and Measurement
  66. Fractional Flow Reserve: Concept and Practical Set Up
  67. FFR-Guided PCI
  68. FFR in Multivessel Disease: Results of the F.A.M.E. Multicenter, International, Randomized Study Comparing FFR guided PCI to Angio guided PCI in Patients with Multivessel CAD
  69. Physiologic Assessment of Coronary Microvascular Dysfunction
  70. Physiologic Study and PCI
Conference Slides
Category